If you use scleral lenses to treat ocular surface disease, note that the Onefit line from Blanchard Contact Lenses has been cleared by the FDA for that indication, the company announced today. The approval is contingent on use of the Optimum Extra, Optimum Extreme or Hexa 100 materials from Contamac, however. Blanchard cites dry eye, Sjögren’s syndrome, graft-vs.-host disease and keratitis as some of the potential diseases amenable to therapy with this modality.
The company notes that the approval should give clinicians greater confidence in ordering Onefit sclerals.
For more information, visit www.blanchardlab.com.